CareLit Fachartikel
The significant effect of saccharomyces boulardii in the microbiota
Zorbay, E. · Aktuelle Ernährungsmedizin · 2024 · Heft 3 · S. 1 bis 1
Dokument
327653
CareLit-ID
Jahr
2024
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
In the human intestine, there are numerous probiotic bacteria, among which Saccharomyces boulardii, a clinically proven, EFSA-approved, patented yeast, is one of them. Saccharomyces boulardii exerts a nanopathogenic effect by strengthening intestinal epithelial cells with compounds, enzymes, and short-chain fatty acids produced in conjunction with the intestinal flora. It has been reported to be effective in the treatment of gastrointestinal disorders in numerous clinical and experimental studies. The primary effect of Saccharomyces boulardii is to inhibit the production of bacterial pathogenic products and prov…
Schlagworte
Gesundheit
Pflege
Diarrhea
Clostridium difficile
Intestinal Mucosa
Clostridium
Bacteria
Germany
After
Bakterien
Aktuelle Ernährungsmedizin
